Ignite Creation Date:
2025-12-24 @ 4:45 PM
Ignite Modification Date:
2026-01-04 @ 3:31 PM
Study NCT ID:
NCT05121350
Status:
UNKNOWN
Last Update Posted:
2022-02-18
First Post:
2021-11-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Clinical Trial to Evaluate the Efficacy and Safety of Anotinib Hydrochloride Capsule Combined With Epirubicin Hydrochloride Versus Placebo Combined With Epirubicin Hydrochloride in First-line Treatment of Advanced Soft Tissue Sarcoma
Sponsor:
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-06
Completion Date Type:
ESTIMATED
First Submit Date:
2021-11-15
First Submit QC Date:
None
Study First Post Date:
2021-11-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-16
Last Update Post Date:
2022-02-18
Last Update Post Date Type:
ACTUAL